These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36916461)

  • 1. Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.
    Pasvolsky O; Saliba RM; Masood A; Mohamedi AH; Tanner MR; Bashir Q; Srour S; Saini N; Ramdial J; Nieto Y; Lee HC; Patel KK; Kebriaei P; Thomas SK; Weber DM; Orlowski RZ; Shpall EJ; Champlin RE; Qazilbash MH
    Br J Haematol; 2023 May; 201(4):e37-e41. PubMed ID: 36916461
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of diet and antibiotics on gut microbiota and outcomes in patients with multiple myeloma treated with autologous hematopoietic stem cell transplantation.
    Pianko MJ
    Leuk Lymphoma; 2023 Jan; 64(1):3-4. PubMed ID: 36398841
    [No Abstract]   [Full Text] [Related]  

  • 3. Edentulism and transplant-associated complications in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation.
    Toro JJ; Gushiken FC; Schneider D; Lee S; Haile DJ; Freytes CO
    Support Care Cancer; 2016 Aug; 24(8):3411-5. PubMed ID: 26984247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of a caregiver is associated with shorter survival in myeloma patients undergoing autologous stem cell transplantation.
    Gertz MA; Warsame R; Muchtar E; Buadi F; Dispenzieri A; Gonsalves W; Dingli D; Hayman S; Kapoor P; Kourelis T; Kumar SK; Lacy MQ; Hogan W
    Leuk Lymphoma; 2022 Oct; 63(10):2422-2427. PubMed ID: 35549799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowing the unknowns in high risk multiple myeloma.
    Derman BA; Kosuri S; Jakubowiak A
    Blood Rev; 2022 Jan; 51():100887. PubMed ID: 34479756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum electrolyte dynamics in multiple myeloma patients undergoing autologous haematopoietic stem cell transplantation.
    Anandan A; Kolk M; Ferrari N; Copley M; Driscoll J; Caimi P; Rashidi A; de Lima M; Malek E
    Nephrology (Carlton); 2020 Jun; 25(6):450-456. PubMed ID: 32167620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoreactive antibodies following autologous peripheral blood stem cell transplantation.
    Ishikawa F; Shigematsu H; Gondo H; Okamura T; Niho Y
    Bone Marrow Transplant; 1998 Oct; 22(7):729-31. PubMed ID: 9818705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma.
    Reynolds C; Ratanatharathorn V; Adams P; Braun T; Silver S; Ayash L; Carson E; Eisbruch A; Dawson LA; McDonagh K; Ferrara J; Uberti J
    Bone Marrow Transplant; 2001 Apr; 27(8):801-7. PubMed ID: 11477436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the role of corrected DLCO in predicting outcomes post autologous hematopoietic cell transplant for multiple myeloma.
    Awada H; Hajj Ali A; Ali MF; Sauter C; Hamilton B; Kalaycio M; Sobecks R; Jagadeesh D; Dean R; Winter A; Pohlman B; Williams L; Anwer F; Khouri J
    Eur J Haematol; 2023 Jun; 110(6):780-783. PubMed ID: 36949569
    [No Abstract]   [Full Text] [Related]  

  • 10. Autologous peripheral blood progenitor cell transplantation for multiple myeloma.
    Attal M; Harousseau JL
    Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):171-91. PubMed ID: 11000991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autologous haematopoietic stem cell transplantation in patients with multiple myeloma complicated by dialysis-dependent renal failure].
    Firsova MV; Mendeleeva LP; Solovev MV; Rekhtina IG; Pokrovskaya OS; Urnova ES; Soboleva NP; Dvirnyk VN; Klyasova GA; Kuzmina LA; Savchenko VG
    Ter Arkh; 2020 Sep; 92(7):70-76. PubMed ID: 33346447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Performance Status and Hematopoietic Cell Transplantation Specific Comorbidity Index on Unplanned Admission Rates in Patients with Multiple Myeloma Undergoing Outpatient Autologous Stem Cell Transplantation.
    Obiozor C; Subramaniam DP; Divine C; Shune L; Singh AK; Lin TL; Abhyankar S; Chen GJ; McGuirk J; Ganguly S
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1641-1645. PubMed ID: 28603071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma.
    Maffini E; Storer BE; Sandmaier BM; Bruno B; Sahebi F; Shizuru JA; Chauncey TR; Hari P; Lange T; Pulsipher MA; McSweeney PA; Holmberg L; Becker PS; Green DJ; Mielcarek M; Maloney DG; Storb R
    Haematologica; 2019 Feb; 104(2):380-391. PubMed ID: 30262560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose melphalan in 1 day versus over 2 days followed by autologous stem cell transplantation as consolidation treatment in patients with multiple myeloma.
    Aydin M; Tang MW; Wondergem MJ; de Leeuw DC; Wegman JJ; Biemond BJ; van de Donk NWCJ; Zweegman S; Meijer E; Nur E
    Br J Haematol; 2022 Mar; 196(6):e67-e70. PubMed ID: 34961917
    [No Abstract]   [Full Text] [Related]  

  • 15. An "impossible" harvest-GCSF-induced immune thrombocytopenia in an autologous stem cell transplant recipient with multiple myeloma.
    Kapoor J; Khushoo V; Garg A; Naim F; Bhatia N; Folbs B; Mehta P; Ahmed R; Agrawal N; Bhurani D; Mirgh SP
    Bone Marrow Transplant; 2021 Jul; 56(7):1737-1739. PubMed ID: 33686246
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
    Kyle RA
    Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity-score matched analysis.
    Patel R; Ma J; Bashir Q; Delgado R; Rondon G; Popat UR; Hosing CM; Nieto Y; Kebriaei P; Alousi AM; Daher M; Mehta R; Srour S; Weber DM; Thomas SK; Lee HC; Patel KK; Orlowski RZ; Shpall ES; Champlin RE; Saini N; Qazilbash MH
    Am J Hematol; 2021 Dec; 96(12):E455-E457. PubMed ID: 34559916
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple cutaneous plasmacytomas following an autologous peripheral stem cell transplant.
    Ah-Weng A; Charles-Holmes R; Rose P; Basu S; Marsden JR; Sanders DS
    Clin Exp Dermatol; 2002 Jun; 27(4):293-5. PubMed ID: 12139674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases.
    Cogbill CH; Drobyski WR; Komorowski RA
    Mod Pathol; 2011 Jan; 24(1):117-25. PubMed ID: 20953169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time from autologous to allogeneic hematopoietic stem cell transplantation impacts post-transplant outcomes in multiple myeloma.
    Fiorenza S; Routledge D; Collins J; Shipton M; Harrison S; Bajel A; Cavet J; Tholouli E; Gauthier J; Ritchie D
    Bone Marrow Transplant; 2020 Jun; 55(6):1172-1174. PubMed ID: 31481801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.